Cargando…
Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
AIMS: This study aimed to investigate the impact of baseline 6 min walk test distance (6MWTD) on time to major cardiovascular (CV) events in heart failure with reduced ejection fraction (HFrEF) and its impact in clinically relevant subgroups. METHODS AND RESULTS: In the WARCEF (Warfarin versus Aspir...
Autores principales: | Matsumoto, Kenji, Xiao, Yi, Homma, Shunichi, Thompson, John L.P., Buchsbaum, Richard, Ito, Kazato, Anker, Stefan D., Qian, Min, Di Tullio, Marco R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006715/ https://www.ncbi.nlm.nih.gov/pubmed/33377631 http://dx.doi.org/10.1002/ehf2.13068 |
Ejemplares similares
-
Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial
por: Ito, Kazato, et al.
Publicado: (2021) -
Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
por: Graham, Susan, et al.
Publicado: (2014) -
Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial
por: Lee, Tetz C., et al.
Publicado: (2019) -
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment
por: Di Tullio, Marco R., et al.
Publicado: (2018) -
The modified Borg/6-min walk distance ratio: a method to assess exertional breathlessness and leg discomfort using the 6-min walk test
por: Ekström, Magnus, et al.
Publicado: (2023)